CognitMarket market news, portfolio research, and investor insights

Your market command center

Research the market. Understand your portfolio. Act with confidence.

Turn market-moving news into a focused daily view of the companies, portfolios, and ideas you care about.

Login
Create my free account
Free to start · No card required

Top Stories

The developments most likely to shape today’s market conversation.
Safe haven search is on Friday as investors keep rotating
Market Summary

Safe haven search is on Friday as investors keep rotating

CNBC.COM

In this article

This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.

Hello, this is Leonie Kidd with today’s edition of Morning Squawk.

There has been a dizzying amount of rotation for investors this week.

But the striking of key levels across equity and bond markets could signal a more significant shift into safe-haven assets.

Here are five key things investors need to know to start the trading day:

It’s been a whiplash week for technology stocks, but Thursday’s sell-off spooked investors enough to seek refuge in safe havens.

Steep declines across the tech space, led by Meta and the chip sector, saw Nasdaq log its worst day since June.

It triggered the biggest one-day decline in the 10-year U.S. Treasury yield since March 2023, driving the level below 5% for the first time in a month.

The market trend is extending into Asia, with Japanese sovereign bonds and the Yen surging amid demand for haven assets.

Volvo Car shares plunged a

Humacyte reports positive trial results for dialysis access device
Company News

Humacyte reports positive trial results for dialysis access device

INVESTING.COM

DURHAM, N.C. - Humacyte Inc. (NASDAQ:HUMA) presented interim results from its V012 Phase 3 clinical trial evaluating an acellular tissue engineered vessel for hemodialysis access in women with end-stage kidney disease, according to a press release statement.

The results were presented Thursday at the American Society of Nephrology’s Kidney Week 2026 in Denver, Colorado. The trial compared the company’s ATEV device against arteriovenous fistula, the current standard of care for hemodialysis access.

In the interim analysis of the first 80 patients, women implanted with the ATEV averaged 220 catheter-free days in the first year compared to 129 days with arteriovenous fistula. The trial met its primary endpoint of superiority, and enrollment was stopped.

ATEV recipients achieved functional access with a median of 1.7 months compared to 5.3 months with an AV fistula. Approximately 65% of AV fistulas achieved functional maturation by month 12, leaving about one-third of women in the fistu

LKQ stock tumbles 10% on weak Q3 results, CEO departure
Company News

LKQ stock tumbles 10% on weak Q3 results, CEO departure

STREETINSIDER.COM

Investing.com -- LKQ Corporation (NASDAQ: LKQ) shares plummeted 10% in Friday morning trading after the automotive parts distributor released preliminary third-quarter 2026 results that missed Wall Street expectations and announced a major executive overhaul.

For the quarter, LKQ expects revenue of $3.32 billion, down from $3.50 billion in the same period last year and short of the $3.41 billion analyst consensus. Adjusted diluted earnings per share (EPS) are projected at $0.47 to $0.53—well below the $0.69 expectation and down sharply from $0.84 in Q3 2025.

Organic revenue for parts and services fell 5.4% year-over-year. The company anticipates a third-quarter net loss of $16 million to $32 million, driven by $111 million in non-cash impairment charges. By comparison, LKQ posted net income of $178 million in Q3 2025.

The disappointing results stem largely from significant underperformance in Europe, where organic parts and services revenue contracted 9.8%. The segment’s EBITDA marg

SpaceX in talks with Crown Castle to secure 80,000 US cell sites
Company News

SpaceX in talks with Crown Castle to secure 80,000 US cell sites

STREETINSIDER.COM

Investing.com -- SpaceX is working to secure at least 80,000 cell sites across the United States and is in discussions with at least one major cellular infrastructure company to achieve this target, according to people familiar with the matter.

The agreements would strengthen the rocket and satellite company's path toward building a fourth nationwide wireless carrier, said the people, who asked not to be identified because the discussions are private. One of the companies in talks with SpaceX is Crown Castle Inc. (NYSE: CCI), which along with American Tower Corp. (NYSE: AMT) and Vertical Bridge Holdings, are among the largest owners of cellular towers.

Crown Castle Chief Executive Officer Chris Hillabrant was asked on Wednesday's earnings conference call whether the company is discussing leases with SpaceX, Amazon.com Inc. (NASDAQ: AMZN) or other satellite-based telecom providers. "You can assume that we're talking to all parties," Hillabrant said. He declined to discuss specific cus

Elicio phase 2 pancreatic cancer trial misses primary endpoint
Company News

Elicio phase 2 pancreatic cancer trial misses primary endpoint

INVESTING.COM

Elicio Therapeutics (Nasdaq: ELTX) reported results from its randomized Phase 2 AMPLIFY-7P study of camupepimut (ELI-002 7P) at the European Society for Medical Oncology Congress 2026 in Madrid, with simultaneous publication in Nature Medicine.

The study, which enrolled 144 patients across 24 U.S. clinical sites, did not meet its pre-specified primary disease-free survival (DFS) endpoint in the intent-to-treat population, recording a hazard ratio of 0.85. The company noted a baseline imbalance in circulating tumor DNA (ctDNA) positivity between arms, with 20.8% of camupepimut patients testing positive at baseline versus 12.5% in the observation arm. Baseline ctDNA positivity was associated with a median DFS of 4.2 months compared to 24.0 months for ctDNA-negative patients across both arms.

Pre-specified subgroup analyses showed favorable treatment-effect trends. In 93 ctDNA-negative patients, median DFS was not reached in the camupepimut arm versus 21.2 months under observation (HR 0

Takeda’s TAK-921 meets dual endpoints in gastric cancer trial
Company News

Takeda’s TAK-921 meets dual endpoints in gastric cancer trial

INVESTING.COM

Takeda Pharmaceutical (4502 / NYSE: TAK) announced that its experimental drug arcotatug tavatecan (TAK-921) met dual primary endpoints of overall survival (OS) and progression-free survival (PFS) in a Phase 3 study of patients with previously treated, CLDN18.2-positive advanced gastric or gastroesophageal junction adenocarcinoma.

Results from the G-HOPE-001 study (NCT06238843) were presented at the 2026 European Society for Medical Oncology Congress. The trial enrolled 464 participants across Japan and China, randomized to receive arcotatug tavatecan or treatment of physician’s choice (TPC), which included irinotecan, paclitaxel, or trifluridine/tipiracil.

In the second interim analysis, with a data cutoff of September 3, 2026, median OS was 10.2 months with arcotatug tavatecan versus 6.9 months with TPC (HR=0.57 [95% CI: 0.45–0.73], P<0.0001). Median PFS per independent radiological review was 7.1 months versus 3.1 months with TPC (HR=0.45 [95% CI: 0.35–0.58]). The confirmed objecti

1 / 6

For You

Personalize this briefing around the investments you care about.

Follow the market through your own lens.

Create a free account to bring watchlist updates, portfolios, and Autopilot status into this briefing.

Trending now

Top portfolios

From the Community

Recent questions, research, and investing ideas from members.

Allegiant Travel (ALGT) has exercised options to acquire six additional Boeing 737-8 aircraft from Boeing (BA). The jets, with a list price exceeding $720 million, are slated for delivery in 2028 . This expands Allegiant's firm order book with Boeing to 56 aircraft, signaling continued fleet modernization and growth plans .

Allegiant Travel exercises Boeing aircraft options and signs new executive contracts

Allegiant Travel exercises Boeing aircraft options and signs new executive contracts

INVESTING.COMOct 23, 10:46 PM UTC
Allegiant exercises options for six Boeing 737 MAX jets worth over $720 million

Allegiant exercises options for six Boeing 737 MAX jets worth over $720 million

INVESTING.COMOct 23, 9:48 PM UTC
1 / 2
0

Concerns over the massive debt tech companies are taking on to finance AI networks are impacting broader markets. The 10-year U.S. Treasury yield dropped below 5% this week, with investors seeking cover amid 'AI worries' . This comes as credit default swaps for some AI companies, like CoreWeave, show distressed levels . The bond market is seeing inflows, with some strategists suggesting 'The Price is Right' for adding bonds after a significant sell-off . This macro shift reflects growing investor apprehension about the financial sustainability of the AI buildout .

10-year Treasury yield drops back to 5% this week as investors seek cover from AI worries

10-year Treasury yield drops back to 5% this week as investors seek cover from AI worries

CNBC.COMOct 23, 8:20 PM UTC
Investors are starting to find opportunities in the battered bond market

Investors are starting to find opportunities in the battered bond market

CNBC.COMOct 23, 5:40 PM UTC
1 / 2
0

LKQ Corporation (NASDAQ: LKQ) shares tumbled 10% after reporting preliminary Q3 2026 results that significantly missed Wall Street expectations. The automotive parts distributor projected revenue of $3.32 billion (vs. $3.41 billion consensus) and adjusted EPS of $0.47-$0.53 (vs. $0.69 consensus), leading to an anticipated net loss of $16M-$32M .

Key points:

  • Organic revenue for parts and services fell 5.4% YoY, with European operations underperforming significantly (-9.8%).
  • CEO Justin Jude and LKQ Europe President Andy Hamilton have departed, with Salvatore A. Abbate named new CEO.
  • Full-year 2026 financial guidance has been withdrawn .

The disappointing results and leadership changes signal significant operational challenges, particularly in Europe.

LKQ stock tumbles 10% on weak Q3 results, CEO departure

LKQ stock tumbles 10% on weak Q3 results, CEO departure

STREETINSIDER.COMOct 23, 12:15 PM UTC
4

Bank of America warns of growing investor reluctance to fund AI infrastructure build-out, citing recent market signals:

  • IPO Withdrawal: AI data center developer Firmus withdrew its IPO due to weak demand .
  • Yield Spikes: CoreWeave's unsecured bond yields touched 15%, and its shares fell 15% .
  • Sector Rotation: MSCI Europe AI Capex Select index is down ~15% since early October, reversing gains. European cyclicals underperformed defensives by 11%, the worst since March 2020 .
  • Semiconductors Hit: Semiconductors are the worst performer, down 15% relative to other sectors .

BofA remains concerned about rising funding costs squeezing returns and potential monetization disappointments, echoing prior capex cycles . This comes as Nvidia's CEO visits Kazakhstan to promote AI computing hubs, highlighting ongoing global AI infrastructure expansion efforts .

BofA sees growing investor reluctance to fund AI infrastructure

BofA sees growing investor reluctance to fund AI infrastructure

STREETINSIDER.COMOct 23, 11:12 AM UTC
Nvidia’s Huang heads to Kazakhstan for the first time — and he’s not the only one with big plans

Nvidia’s Huang heads to Kazakhstan for the first time — and he’s not the only one with big plans

CNBC.COMOct 23, 9:21 AM UTC
1 / 2
3

SpaceX is in talks with Crown Castle (CCI) and other tower companies to secure 80,000 cell sites, signaling a major push to become a fourth nationwide wireless carrier.

  • Market Reaction: Crown Castle shares surged 10% on the news, while incumbent carriers AT&T (T), Verizon (VZ), and T-Mobile (TMUS) each fell around 5% .
  • Strategic Impact: This move could significantly disrupt the telecom landscape, creating a new competitor for mobile services and a substantial new revenue stream for tower operators .
  • Scale: The potential deals could be worth billions, as SpaceX aims to leverage its satellite technology with terrestrial infrastructure .
SpaceX in talks with Crown Castle to secure 80,000 US cell sites

SpaceX in talks with Crown Castle to secure 80,000 US cell sites

STREETINSIDER.COMOct 23, 8:27 AM UTC
2

New US unemployment claims fell to 194,000 last week, with the 4-week average at 197,750 – the lowest levels since 1969 . This 'low-hire, low-fire' labor market signals stability but also potential stagnation. The data reinforces the Federal Reserve's challenge in balancing its dual mandate of low inflation and low unemployment, potentially supporting continued interest rate hikes .

Unemployment Lines Are Shorter Than Any Time Since The 1960s

Unemployment Lines Are Shorter Than Any Time Since The 1960s

INVESTOPEDIA.COMOct 22, 9:06 PM UTC
4

The AI-related technology sector continues its broad retreat, with Celestica (CAD) shares tumbling 11.5% today amid pre-earnings risk reduction, insider selling, and a bearish technical pattern . The NASDAQ fell 2.6% as investors dumped AI names, including Nvidia, AMD, Broadcom, and Marvell Technology .

Even strong earnings reports are not immune: Western Digital (WDC) initially surged 4% after beating Q1 estimates and providing upbeat guidance, but subsequently erased all gains as the AI selloff extended . This indicates a strong bearish sentiment overriding positive company-specific news.

Key points:

  • Celestica (CAD): Down 11.5% on AI tech selloff, pre-earnings caution, insider sales.
  • Western Digital (WDC): Q1 beat and strong guidance negated by sector-wide selling.
  • Broader Impact: NASDAQ down 2.6%, with major AI players retreating .
Why is Celestica stock tumbling today?

Why is Celestica stock tumbling today?

INVESTING.COMOct 22, 7:07 PM UTC
Western Digital beats earnings estimates, but AI selloff erases initial gains

Western Digital beats earnings estimates, but AI selloff erases initial gains

STREETINSIDER.COMOct 22, 8:13 PM UTC
1 / 2
6

Freedom Broker has issued a sweeping downgrade across major North American gold producers, citing trimmed EBITDA forecasts, operational risks, and valuation constraints. This led to significant share price drops:

  • Agnico Eagle (AEM): Downgraded to Hold, PT cut to $212 (from $255) on valuation premium and revised 2027 EBITDA.
  • Barrick Mining (B): Downgraded to Hold, PT cut to $46 (from $54) due to near-term earnings estimate reductions.
  • Newmont (NEM): Downgraded to Hold, PT cut to $116 (from $130) on cost inflation and performance risks.

RBC Capital Markets also noted gold producers face margin pressure in Q3 from lower gold prices and elevated costs, despite expected production improvements .

Agnico, Barrick, and Newmont fall following broad Freedom Broker downgrades

Agnico, Barrick, and Newmont fall following broad Freedom Broker downgrades

STREETINSIDER.COMOct 22, 2:56 PM UTC
Gold miners face margin pressure as lower prices complicate third-quarter results

Gold miners face margin pressure as lower prices complicate third-quarter results

STREETINSIDER.COMOct 22, 7:58 PM UTC
1 / 2
6

US stock futures and major indices are sharply lower, led by a broad sell-off in the tech sector. Concerns over the long-term sustainability of AI infrastructure spending and rising borrowing costs are weighing on sentiment . Chip stocks, including Marvell Technology (-5%), Micron, Sandisk, Seagate, and Western Digital, are under pressure . Mega-cap tech names like Meta Platforms (-7%) and Tesla (-5.2%) are also declining despite mixed earnings reactions .

Key points:

  • AI Spending Doubts: Warnings from chip executives about capital access becoming a constraint on AI expansion and clouding ROI .
  • Broad Tech Weakness: Nasdaq Composite down 2.2%, S&P 500 down 1.2% .
  • Geopolitical Headwinds: Oil prices surge on Middle East escalations, contributing to a broad risk-off tone .
  • Memory Glut Fears: Nvidia CEO Jensen Huang attempts to counter concerns about a 2029 memory glut, but memory stocks remain under pressure .
Why is Marvell Technology stock sliding today?

Why is Marvell Technology stock sliding today?

INVESTING.COMOct 22, 1:46 PM UTC
Stock Market Today: Nasdaq, S&P 500 Dive, Led Lower by Tech Stocks; Oil Prices Surge on Middle East Escalations; 10-Year Yield Sinks Below 5%

Stock Market Today: Nasdaq, S&P 500 Dive, Led Lower by Tech Stocks; Oil Prices Surge on Middle East Escalations; 10-Year Yield Sinks Below 5%

INVESTOPEDIA.COMOct 22, 4:45 PM UTC
Sellers are back in tech, while bear market grips Chinese stocks

Sellers are back in tech, while bear market grips Chinese stocks

CNBC.COMOct 22, 11:50 AM UTC
JPMorgan says tech stocks lead U.S. futures lower on risks

JPMorgan says tech stocks lead U.S. futures lower on risks

STREETINSIDER.COMOct 22, 12:50 PM UTC
Nvidia’s Jensen Huang says he sees no sign of a 2029 memory glut: ‘You can always use more’

Nvidia’s Jensen Huang says he sees no sign of a 2029 memory glut: ‘You can always use more’

CNBC.COMOct 22, 1:12 PM UTC
Tech Slump Hits Memory, Data Storage Stocks With Western Digital Earnings Due Later Today

Tech Slump Hits Memory, Data Storage Stocks With Western Digital Earnings Due Later Today

INVESTOPEDIA.COMOct 22, 3:00 PM UTC
1 / 6
6

The tech sector is facing significant headwinds today, with a broad sell-off impacting chip stocks and AI-linked companies. Concerns over the long-term sustainability of AI infrastructure spending and rising borrowing costs are rattling investor confidence .

Key movements:

  • Marvell Technology (MRVL) slid 5.0% as optical communications and AI-linked semiconductor stocks faced coordinated risk-off pressure .
  • Tesla (TSLA) fell 5.2% in premarket trading despite better-than-expected Q3 results, weighed down by lower average car sales prices and a battery supply crunch .
  • Meta Platforms (META) reversed initial gains to trade down 2% following its earnings report .
  • Nvidia (NVDA) declined 2.4% , though CEO Jensen Huang dismissed concerns of a 2029 memory glut, stating 'you can always use more' .

The NASDAQ fell 1.5%, reflecting a broader risk-off sentiment across U.S. equities .

Sellers are back in tech, while bear market grips Chinese stocks

Sellers are back in tech, while bear market grips Chinese stocks

CNBC.COMOct 22, 11:50 AM UTC
Why is Marvell Technology stock sliding today?

Why is Marvell Technology stock sliding today?

INVESTING.COMOct 22, 1:46 PM UTC
Nvidia’s Jensen Huang says he sees no sign of a 2029 memory glut: ‘You can always use more’

Nvidia’s Jensen Huang says he sees no sign of a 2029 memory glut: ‘You can always use more’

CNBC.COMOct 22, 1:12 PM UTC
JPMorgan says tech stocks lead U.S. futures lower on risks

JPMorgan says tech stocks lead U.S. futures lower on risks

STREETINSIDER.COMOct 22, 12:50 PM UTC
1 / 4
6